Protective Effect of KBT-3022, a New Cyclooxygenase Inhibitor, in Cerebral Hypoxia and Ischemia.

The Japanese Journal of Pharmacology
doi 10.1254/jjp.69.421
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Pharmacological Society

Related search

Clinical Pharmacology of a New Antiplatelet Drug, KBT-3022. Results of Single Administration in Japanese Healthy Adults.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1990English

A Comparison of the Protective Effect of Dexamethasone to Other Potential Prophylactic Agents in a Neonatal Rat Model of Cerebral Hypoxia-Ischemia

Journal of Neurosurgery
SurgeryNeurology
1993English

Anti-Thrombotic Activity of KBT-3022 in Experimental Models of Thrombosis.

The Japanese Journal of Pharmacology
1995English

Ultrasound-Enhanced Protective Effect of Tetramethylpyrazine Against Cerebral Ischemia/Reperfusion Injury

PLoS ONE
Multidisciplinary
2014English

Protective Role of Arginase II in Cerebral Ischemia and Excitotoxicity

Journal of Neurology and Neuroscience
2016English

Protective Effect of Flavonoids From Scutellaria Baicalensis Georgi on Cerebral Ischemia Injury

Journal of Ethnopharmacology
Drug DiscoveryPharmacology
2006English

Inhibitory Effects of the New Anti-Platelet Agent KBT-3022 and Its Metabolite on Rabbit Neutrophil Function in Vitro.

The Japanese Journal of Pharmacology
1996English

Protective Effect of Autophagy in Neural Ischemia and Hypoxia: Negative Regulation of the WNT/Β-Catenin Pathway

International Journal of Molecular Medicine
MedicineGenetics
2017English

Ca2+ MACROIMAGING IN CEREBRAL CORTEX OF YOUNG RATS IN HYPOXIA-ISCHEMIA 39

Pediatric Research
Child HealthPediatricsPerinatology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy